Postes actifs de Bernard Pau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Phost’in SAS
 Phost’in SAS Pharmaceuticals: MajorHealth Technology Phost’In SAS operates as a biotechnology company, which engages in the discovery and development of N-glycosylation inhibitors. Its potent anti-cancer new chemical entities specifically targeting abnormal pathogenic glycosylation mechanisms. The company was founded by Karine Chorro and Ludovic Clarion in December 2014 and is headquartered in France. | Président | 17/06/2020 | - |
| Directeur des opérations | 17/06/2020 | - |
Historique de carrière de Bernard Pau
Anciens postes connus de Bernard Pau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biodol Therapeutics SAS
 Biodol Therapeutics SAS BiotechnologyHealth Technology Biodol Therapeutics SAS engages in the development of compounds for the treatment of chronic pain. It specializes in parallel small-molecule FLT3 inhibitors. The company was founded by Fabien Granier, Pierre Sokoloff and Bernard Pau in 2015 and is headquartered in Clapiers, France. | Fondateur | 01/01/2015 | - |
Statistiques
Internationale
| France | 3 |
Opérationnelle
| Chairman | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Phost’in SAS
Phost’in SAS Pharmaceuticals: MajorHealth Technology Phost’In SAS operates as a biotechnology company, which engages in the discovery and development of N-glycosylation inhibitors. Its potent anti-cancer new chemical entities specifically targeting abnormal pathogenic glycosylation mechanisms. The company was founded by Karine Chorro and Ludovic Clarion in December 2014 and is headquartered in France. | Health Technology |
Biodol Therapeutics SAS
Biodol Therapeutics SAS BiotechnologyHealth Technology Biodol Therapeutics SAS engages in the development of compounds for the treatment of chronic pain. It specializes in parallel small-molecule FLT3 inhibitors. The company was founded by Fabien Granier, Pierre Sokoloff and Bernard Pau in 2015 and is headquartered in Clapiers, France. | Health Technology |
- Bourse
- Insiders
- Bernard Pau
- Expérience
